Home
Clinical Trials
System to Evaluate the Risk o...

System to Evaluate the Risk of Lymph Node Metastasis Preoperatively in Cervical Cancer

Last Updated: 2023-09-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

426 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-01-01

Study Completion Date

2023-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The lymph node status is difficult to be assessed preoperatively, this study aimed to develop a scoring system for predicting the risk of LNM in cervical cancer patients before operation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological Images

NCT06399159

Papillary Thyroid Carcinoma Lymph Node Metastasis

COMPLETED

Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma

NCT02648399

Thyroid Papillary Carcinoma

UNKNOWN NA

Bilateral Elective Neck Dissection in Salvage Total Laryngectomy

NCT05746780

Neck Cancer Larynx Larynx Cancer +1 more

COMPLETED

Central Cervical Dissection for Clinical Node Negative Papillary Thyroid Carcinoma

NCT03813173

Lymph Node Metastases

NOT_YET_RECRUITING NA

Identification of Surgical Management of Lymph Node Basins and Surgical Practice Patterns Among Sarcoma Surgeons

NCT04553744

Soft Tissue Sarcoma Lymph Node Cancer

WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Lymph nodes metastasis (LNM) was proved to be a critical risk factor related to the survival to cervical cancer survival. However, preoperative pelvic magnetic resonance imaging (MR) or computed tomography (CT) tests are less sensitive to assess the risk of lymph node metastasis. PET-CT is too expensive and radiative to be widely used in clinical practice. A model was constructed based on clinical indicators to predict lymph node metastasis preoperatively, providing a reference for clinical treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

surgery

Patients confirmed cervical cancer were undergone radical hysterectomy with pelvic lymphadenectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of cervical cancer
* FIGO stage IB1-IIA1
* Undergone radical hysterectomy with pelvic lymphadenectomy
* Peformed pelvic MRI examination preoperatively

Exclusion Criteria

* Had distant metastases diagnosed before or during the surgery
* Underwent neoadjuvant radiotherapy preoperatively
* Underwent neoadjuvant chemotherapy preoperatively
* Incomplete or inaccuratemedical records

Minimum Eligible Age

25 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers